Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REFLO-STEMI
NCT01747174Phase 2Completed
- Sponsor
- University Hospitals of Leicester NHS Trust
- Start
- Oct 2011
- Primary completion
- Oct 2014
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of adenosine, sodium nitroprusside in ST elevation myocardial infarction (STEMI), sponsored by University Hospitals of Leicester NHS Trust. Started Oct 2011; status: completed.
02
Drugs
adenosinesodium nitroprusside
03
Conditions
ST elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT01747174.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01747174.